As findings from large prospective studies and clinical trials have demonstrated that delaying ART can result in increased overall mortality risk associated with AIDS [2], [4], [7], [12]–[14], new guidelines recommend early ART initiation in patients with tuberculosis and severe CD4+ T-cell depletion [15]. Here, CD4 is linked to tuberculosis.